We are live on
!
Find out more
OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
Turnover
87.07%
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.62%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$491M
AUM Growth
-$1.05B
(-68%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-228.79%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
648
New
56
Increased
90
Reduced
399
Closed
62
Avg Time Held
2.6
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.3M |
| 2 |
State Street
STT
|
+$1.21M |
| 3 |
Ball Corp
BALL
|
+$1.18M |
| 4 |
Target
TGT
|
+$1.04M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$955K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$51.4M |
| 2 |
Visa
V
|
+$42.4M |
| 3 |
Merck
MRK
|
+$41.1M |
| 4 |
Nike
NKE
|
+$40.8M |
| 5 |
Walt Disney
DIS
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Financials | 16.11% |
| 3 | Healthcare | 15.07% |
| 4 | Consumer Discretionary | 11.49% |
| 5 | Industrials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.99T
| $13.4M | 2.72% |
182,052
-799,636
| -81% | -$51.4M |
2013 Q2
26 quarters
|
|
2
Microsoft
MSFT
$4.01T
| $11.1M | 2.26% |
70,365
-174,982
| -71% | -$25.7M |
2013 Q2
26 quarters
|
|
3
Alphabet (Google) Class A
GOOGL
$4.27T
| $8.28M | 1.69% |
123,660
-359,760
| -74% | -$23.2M |
2015 Q4
16 quarters
|
|
4
Amazon
AMZN
$2.75T
| $7.43M | 1.51% |
80,400
-184,900
| -70% | -$16.4M |
2013 Q2
26 quarters
|
|
5
JPMorgan Chase
JPM
$891B
| $5.91M | 1.2% |
42,391
-63,163
| -60% | -$8.1M |
2013 Q2
26 quarters
|
|
6
Meta Platforms (Facebook)
META
$1.88T
| $5.36M | 1.09% |
26,112
-57,800
| -69% | -$11.2M |
2013 Q2
26 quarters
|
|
7
Berkshire Hathaway Class B
BRK.B
$1.13T
| $5.27M | 1.07% |
23,285
-26,000
| -53% | -$5.65M |
2013 Q2
26 quarters
|
|
8
UnitedHealth
UNH
$365B
| $5.19M | 1.06% |
17,650
-26,750
| -60% | -$7M |
2013 Q2
26 quarters
|
|
9
Johnson & Johnson
JNJ
$610B
| $5.13M | 1.04% |
35,180
-32,944
| -48% | -$4.47M |
2013 Q2
26 quarters
|
|
|
10
Walt Disney
DIS
$191B
| $4.95M | 1.01% |
34,241
-290,394
| -89% | -$40.5M |
2013 Q2
26 quarters
|
|
|
11
Merck
MRK
$358B
| $4.47M | 0.91% |
51,527
-500,510
| -91% | -$41.1M |
2013 Q2
26 quarters
|
|
12
Medtronic
MDT
$122B
| $4.28M | 0.87% |
37,688
-339,141
| -90% | -$37.2M |
2013 Q2
26 quarters
|
|
13
Wells Fargo
WFC
$248B
| $3.9M | 0.79% |
72,555
-81,195
| -53% | -$4.25M |
2013 Q2
26 quarters
|
|
14
Bank of America
BAC
$362B
| $3.85M | 0.78% |
109,309
-129,761
| -54% | -$4.19M |
2013 Q2
26 quarters
|
|
15
Cisco
CSCO
$433B
| $3.78M | 0.77% |
78,875
-91,032
| -54% | -$4.23M |
2013 Q2
26 quarters
|
|
16
Mastercard
MA
$540B
| $3.63M | 0.74% |
12,152
-23,755
| -66% | -$6.7M |
2013 Q2
26 quarters
|
|
|
17
Pfizer
PFE
$168B
| $3.61M | 0.73% |
97,096
+36,625
| +61% | +$1.3M |
2013 Q2
26 quarters
|
|
18
Intel
INTC
$504B
| $3.53M | 0.72% |
59,000
-49,229
| -45% | -$2.75M |
2013 Q2
26 quarters
|
|
|
19
Nike
NKE
$55.2B
| $3.51M | 0.71% |
34,623
-433,279
| -93% | -$40.8M |
2013 Q2
26 quarters
|
|
20
PepsiCo
PEP
$175B
| $3.36M | 0.68% |
24,570
-273,444
| -92% | -$37.2M |
2013 Q2
26 quarters
|
|
21
Home Depot
HD
$308B
| $3.22M | 0.66% |
14,764
-132,567
| -90% | -$30M |
2013 Q2
26 quarters
|
|
22
Mondelez International
MDLZ
$80.4B
| $2.93M | 0.6% |
53,274
-665,235
| -93% | -$35.6M |
2013 Q2
26 quarters
|
|
23
Boeing
BA
$149B
| $2.77M | 0.56% |
8,487
-13,491
| -61% | -$4.78M |
2013 Q2
26 quarters
|
|
|
24
Visa
V
$750B
| $2.73M | 0.56% |
14,545
-235,592
| -94% | -$42.4M |
2013 Q2
26 quarters
|
|
25
Citigroup
C
$207B
| $2.68M | 0.55% |
33,580
-46,370
| -58% | -$3.43M |
2013 Q2
26 quarters
|
|
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q4 2019 Portfolio in Review
As of Q4 2019, Oakbrook Investments held 648 positions worth $491M, down 68% from $1.54B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Oakbrook Investments withdrew a net $1.12B in Q4 2019, closing 62 positions and reducing 399 holdings. Its most notable exit was 3M, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Oakbrook Investments opened a new position in State Street worth $1.36M.
- Oakbrook Investments's largest Q4 2019 buy was State Street: 17,250 shares worth $1.36M.
- Oakbrook Investments added most to Pfizer in Q4 2019, an estimated $1.3M increase.
- Oakbrook Investments's biggest Q4 2019 reduction was Apple, cutting an estimated $51.4M.
- Oakbrook Investments fully exited 3M in Q4 2019, selling an estimated $22.6M.
- Oakbrook Investments's ten largest holdings make up 15% of its $491M portfolio in Q4 2019.
- Oakbrook Investments opened 56 new positions and closed 62 in Q4 2019.
- Oakbrook Investments's portfolio value fell 68% quarter-over-quarter to $491M.
Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.